168 related articles for article (PubMed ID: 29972964)
1. [Effect of treatment of infant parotid hemangioma with no response to oral propranolol].
Tian Y; Guo XS; Nan J; Wang XL; Shen G
Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Jan; 53(1):49-51. PubMed ID: 29972964
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Arterial Sclerosing Embolization for the Treatment of Giant Propranolol-Resistant Infantile Hemangiomas in the Parotid Region.
Guo L; Wu C; Song D; Wang L; Li J; Sun J; Zhang Y
J Vasc Interv Radiol; 2021 Feb; 32(2):293-298. PubMed ID: 33221193
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of infantile parotid hemangioma with propranolol].
Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
[TBL] [Abstract][Full Text] [Related]
4. Success in the use of oral propranolol in the treatment of infantile hemangioma in nasal tip - Report of two cases.
Costa MC; Andrade OGC; Pereira LC; Costa IMC
An Bras Dermatol; 2020; 95(2):207-209. PubMed ID: 32061465
[TBL] [Abstract][Full Text] [Related]
5. Oral propranolol for parotid infantile hemangiomas.
Li G; Xu DP; Sun HL; Cheng C; Liu ZM; Xi SL; Wang XK
J Craniofac Surg; 2015 Mar; 26(2):438-40. PubMed ID: 25692890
[TBL] [Abstract][Full Text] [Related]
6. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of propranolol in the treatment of parotid hemangioma.
Morais P; Magina S; Mateus M; Trindade E; Jesus JM; Azevedo F
Cutan Ocul Toxicol; 2011 Sep; 30(3):245-8. PubMed ID: 21338243
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report.
Furuta S; Sato H; Tsuji S; Murakami F; Kitagawa H
Pediatr Surg Int; 2016 Sep; 32(9):857-62. PubMed ID: 27461431
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma.
Goto K; Ozeki M; Yasue S; Endo S; Fukao T
Pediatr Int; 2020 Jun; 62(6):751-753. PubMed ID: 32490577
[No Abstract] [Full Text] [Related]
11. [Use of beta blockers--a new perspective in therapy of infantile hemangiomas of the head and neck area].
Eivazi B; Teymoortash A; Stiller S; Cremer H; Werner JA
Laryngorhinootologie; 2010 Apr; 89(4):230-1. PubMed ID: 19728258
[No Abstract] [Full Text] [Related]
12. [Subsequent therapy for infantile hemangiomas after discontinuation of oral propranolol].
Tai MZ; Liu XJ; Qin ZP; Ge CX; Li KL; Chen T
Shanghai Kou Qiang Yi Xue; 2015 Dec; 24(6):716-20. PubMed ID: 27063125
[TBL] [Abstract][Full Text] [Related]
13. [Propranolol for treatment of subglottic hemangioma].
Kurzyna A; Hassmann-Poznańska E; Wójtowicz J; Bossowski A
Otolaryngol Pol; 2010; 64(6):388-91. PubMed ID: 21302508
[TBL] [Abstract][Full Text] [Related]
14. Hemangioma of the parotid gland: case report.
Popescu E; Trandafir V; Negru D; Dobrin N; Trandafir D
Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):227-32. PubMed ID: 24505920
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
16. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
Pope E; Chakkittakandiyil A; Lara-Corrales I; Maki E; Weinstein M
Br J Dermatol; 2013 Jan; 168(1):222-4. PubMed ID: 22762503
[No Abstract] [Full Text] [Related]
17. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
18. Use of propranolol for parotid hemangioma.
Chang L; Jin Y; Lv D; Ying H; Wang T; Qiu Y; Ma G; Chen H; Yu W; Yang X; Lin X
Head Neck; 2016 Apr; 38 Suppl 1():E1730-6. PubMed ID: 26676449
[TBL] [Abstract][Full Text] [Related]
19. Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).
Janmohamed SR; van Oosterhout M; de Laat PC; van Rosmalen J; Madern GC; Oranje AP
J Am Acad Dermatol; 2015 Aug; 73(2):258-63. PubMed ID: 26183969
[TBL] [Abstract][Full Text] [Related]
20. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
Li XY; Wang Y; Jin L; Chen JR
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
